Growth in transplant diagnostics market driven by increasing demand for liver and heart transplants

Transplant Diagnostics Market

Due to the very reliable results provided by these tests. Coupled with this, molecular tests used to perform diagnostic transplantation procedures.

The segment of non-molecular assays is expected to experience steady growth, owing to the advent of technological change in the market. Molecular testing is expected to dominate the technology segment ”

– Allied market research

PORTLAND, OR, UNITED STATES, October 5, 2021 /EINPresswire.com/ – The increase in the incidence of organ failure due to the increase in chronic disease cases, the increase in the aging population and the increased attention to R&D is expected to propel the global market growth. transplant diagnostics market. Chronic diseases can lead to organ failure in patients, which could be an important target audience for diagnostic transplant procedures. However, difficulties in human leukocyte antigen (HLA) sequencing and growing global organ shortage may hamper the market growth.

The Transplant Diagnostics Market report provides an overview of the market based on key parameters such as market size, sales, sales analysis, and major drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus (COVID-19) epidemic has affected all aspects of life around the world. It changed part of the market situation. The main objective of the research report is to provide users with an overview of the market. Initial and future assessments quickly.

Get a sample PDF of the report @ https://www.alliedmarketresearch.com/request-sample/1135

Reagents and consumables segment accounted for the maximum revenue generation in 2020, due to the increase in the number of diagnostic procedures before and after organ transplantation. The instrument and equipment segment is expected to grow at a high CAGR. Both technologies, namely non-molecular assay and molecular assay, occupy an important position in the global transplant diagnostics market. However, the molecular analysis technology segment is expected to grow at the highest CAGR, due to the very precise results provided by modern molecular analysis technology.

The uptake of transplant diagnostics (including pre- and post-transplant screening) is expected to increase significantly as the prevalence of chronic diseases that can lead to organ failure increases. The market has aroused the interest of healthcare providers due to the various advantages offered by these tests to assess the feasibility of the organ transplant procedure. There have been significant technological advances in the diagnosis of transplants to provide advanced diagnostic options for the management of organ transplants. The market is in a phase of maturity in developed countries, while emerging regions such as LAMEA and Asia-Pacific hold potential opportunities for transplant diagnostics.

With the increase in the number of kidney transplants, the segment is expected to generate high revenue in the future, with a CAGR of 9.8%, due to the increase in the incidence of kidney failure worldwide. . Liver and heart transplants are estimated to have a high growth rate over the expected duration, due to increased sensitization to organ donation and increased incidence of liver failure and cardiac.

North America accounted for a major market share in 2020, with maximum contribution to US revenue, due to the large number of kidney, liver, lung, heart and pancreas transplant procedures. Adoption of the latest technology and increased awareness of organ transplantation in the United States has boosted the North American market for transplant diagnostics. The Asia-Pacific region offers lucrative opportunities for transplant diagnostics market players to expand their market presence. This region has the highest geriatric population and the scenario is expected to continue; further decline in the growth of the transplant diagnostics market.

For a purchase request @ https://www.alliedmarketresearch.com/purchase-enquiry/1135

The report also provides a comprehensive analysis of major players operating in the global transplant diagnostics market such as Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor , Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen NV, Thermo Fisher Scientific Inc. and Sigma-Aldrich, among others. The report presents a competitive market research by analyzing the market shares and position of key players, recent strategic moves, and detailed profiles of these players.

Similar research reports:

Proteomics Market Expected to Reach $ 49.97 Billion by 2027

PPH Device Market To Reach $ 906 Million Globally By 2030

AVENUE – A subscription-based library (Premium on-demand, subscription-based pricing model):

AMR presents its premium online subscription-based Avenue library, designed specifically to provide a one-stop, cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. In addition, users can access quantitative and qualitative data online in PDF and Excel formats, as well as analyst support, customization and updated versions of reports.

Access the report library anytime from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Electricity, semiconductors and electronics, automotive and transportation, ICT and media, aerospace and defense and BFSI.

We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Each of the data presented in the reports we publish is extracted through primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.

David Corréa
Allied Analytics srl
+1 800-792-5285
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn

David Corréa
Allied Analytics srl
+1 503-894-6022
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *